Cargando…
Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019
BACKGROUND: This study analyzed serum concentrations of interleukin (IL)-22 and IL-33 (pro-inflammatory and anti-inflammatory cytokines) in 90 patients with mild/moderate coronavirus disease 2019 (COVID-19) and 90 healthy controls. Enzyme-linked immunosorbent assay kits were used to measure IL-22 an...
Autores principales: | Majeed, Abdulraheem Y., Zulkafli, Nor Effa S., Ad’hiah, Ali H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968467/ https://www.ncbi.nlm.nih.gov/pubmed/36875710 http://dx.doi.org/10.1186/s43088-023-00367-8 |
Ejemplares similares
-
Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
por: Majeed, Abdulraheem Y., et al.
Publicado: (2023) -
Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)
por: Ahmed, Aeshah A., et al.
Publicado: (2021) -
Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients
por: Ahmed, Aeshah A., et al.
Publicado: (2022) -
Interleukin‐39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index
por: Nussrat, Shahad W., et al.
Publicado: (2023) -
Evaluation of interleukins 37 and 38 and vitamin D status in the serum of women with Graves' disease
por: Ibrahim, Hiba Y., et al.
Publicado: (2022)